Neuropace, Inc. NPCE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s total equity?
- Neuropace, Inc. (NPCE) reported total equity of $14.45M in Q1 2026.
- How has Neuropace, Inc.'s total equity changed year-over-year?
- Neuropace, Inc.'s total equity decreased by 40.4% year-over-year, from $24.27M to $14.45M.
- What is the long-term trend for Neuropace, Inc.'s total equity?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s total equity has grown at a -33.6% compound annual growth rate (CAGR), from -$147.83M to $19.03M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.